Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Monday.
TCMD has been the topic of a number of other reports. Oppenheimer cut shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. BTIG Research cut shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Finally, B. Riley began coverage on shares of Tactile Systems Technology in a research note on Thursday, September 26th. They issued a “buy” rating and a $23.00 price target on the stock.
Get Our Latest Report on Tactile Systems Technology
Tactile Systems Technology Stock Down 3.1 %
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of TCMD. Paradigm Capital Management Inc. NY grew its stake in Tactile Systems Technology by 90.1% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock valued at $14,135,000 after buying an additional 561,073 shares during the last quarter. Pinnacle Associates Ltd. grew its stake in Tactile Systems Technology by 324.9% in the 2nd quarter. Pinnacle Associates Ltd. now owns 317,024 shares of the company’s stock valued at $3,785,000 after buying an additional 242,413 shares during the last quarter. Essex Investment Management Co. LLC acquired a new position in shares of Tactile Systems Technology during the 3rd quarter worth approximately $1,803,000. Los Angeles Capital Management LLC acquired a new position in shares of Tactile Systems Technology during the 2nd quarter worth approximately $1,187,000. Finally, Federated Hermes Inc. grew its position in shares of Tactile Systems Technology by 26.5% during the 2nd quarter. Federated Hermes Inc. now owns 433,660 shares of the company’s stock worth $5,178,000 after purchasing an additional 90,960 shares in the last quarter. Institutional investors and hedge funds own 83.43% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.